Endocrinology, Vol 137, 2278-2285, Copyright © 1996 by Endocrine Society

ARTICLES

T lymphocytes play a critical role in the development of cyclosporin A- induced osteopenia

FJ Buchinsky, Y Ma, GN Mann, B Rucinski, HP Bryer, DF Romero, WS Jee and S Epstein
Department of Endocrinology and Metabolism, Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141, USA.

The T lymphocyte suppressor, cyclosporin A, has been shown to cause high turnover osteoporosis. We postulated that cyclosporin A may exert its effects via the T cell rather than direct activity on bone. In this study we administered cyclosporin A (15 mg/kg.day by gavage) to 11 10- week-old Rowett athymic nude rats and to 12 age-matched immunocompetent Sprague-Dawley rats. Placebo was administered to control groups (n = 12 for both). After 28 days of treatment, the Sprague-Dawley rats displayed high turnover bone loss, but the nude rats were largely unaffected by the drug. Sprague-Dawley treated rats had less than half the percent trabecular area of their controls as measured at the secondary spongiosa of the proximal tibial metaphysis (P < 0.001; strain by treatment, P = 0.007). The same pattern was evident for trabecular number, separation, and thickness (strain by treatment, P = 0.034, P = 0.001, and P = 0.021, respectively). Only the Sprague-Dawley rats had an elevated percent eroded perimeter and an elevated bone area referent bone formation rate (strain by treatment, P = 0.002 and P = 0.0003, respectively). Mass, glucose, ionized calcium, PTH, osteocalcin, 1,25-dihydroxyvitamin D, and creatinine all responded similarly to cyclosporin A regardless of strain. T Lymphocytes thus appear to be a prerequisite for the development of cyclosporin A- induced osteopenia.

This article has been cited by other articles:

				L. Sun, H. C. Blair, Y. Peng, N. Zaidi, O. A. Adebanjo, X. B. Wu, X. Y. Wu, J. Iqbal, S. Epstein, E. Abe, et al. Calcineurin regulates bone formation by the osteoblast PNAS, November 22, 2005; 102(47): 17130 - 17135. [Abstract] [Full Text] [PDF]

				T. Kawahara, S. Murakami, Y. Noiri, A. Ehara, N. Takemura, S. Furukawa, and S. Ebisu Effects of Cyclosporin-A-induced Immunosuppression on Periapical Lesions in Rats J. Dent. Res., September 1, 2004; 83(9): 683 - 687. [Abstract] [Full Text] [PDF]

				L. Sun, B. S. Moonga, M. Lu, N. Zaidi, J. Iqbal, H. C. Blair, S. Epstein, E. Abe, B. R. Troen, C. L.-H. Huang, et al. Molecular cloning, expression, and function of osteoclastic calcineurin Aalpha Am J Physiol Renal Physiol, March 1, 2003; 284(3): F575 - F583. [Abstract] [Full Text] [PDF]

				R. G. Erben, K. S. Brunner, B. Breig, J. Eberle, M. Goldberg, and L. C. Hofbauer Skeletal Effects of Cyclosporin A Are Gender Related in Rats Endocrinology, January 1, 2003; 144(1): 40 - 49. [Abstract] [Full Text] [PDF]

				D. Grcevic, S.-K. Lee, A. Marusic, and J. A. Lorenzo Depletion of CD4 and CD8 T Lymphocytes in Mice In Vivo Enhances 1,25-Dihydroxyvitamin D3-Stimulated Osteoclast-Like Cell Formation In Vitro by a Mechanism That Is Dependent on Prostaglandin Synthesis J. Immunol., October 15, 2000; 165(8): 4231 - 4238. [Abstract] [Full Text] [PDF]

				P. J. Baker, M. Dixon, R. T. Evans, L. Dufour, E. Johnson, and D. C. Roopenian CD4+ T Cells and the Proinflammatory Cytokines Gamma Interferon and Interleukin-6 Contribute to Alveolar Bone Loss in Mice Infect. Immun., June 1, 1999; 67(6): 2804 - 2809. [Abstract] [Full Text] [PDF]